An orally administered butyrate‐releasing derivative reduces neutrophil recruitment and inflammation in dextran sulphate sodium‐induced murine colitis

BACKGROUND AND PURPOSE: Butyrate has shown benefits in inflammatory bowel diseases. However, it is not often administered orally because of its rancid smell and unpleasant taste. The efficacy of a more palatable butyrate‐releasing derivative, N‐(1‐carbamoyl‐2‐phenylethyl) butyramide (FBA), was evalu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Br J Pharmacol
Autores principales: Simeoli, Raffaele, Mattace Raso, Giuseppina, Pirozzi, Claudio, Lama, Adriano, Santoro, Anna, Russo, Roberto, Montero‐Melendez, Trinidad, Berni Canani, Roberto, Calignano, Antonio, Perretti, Mauro, Meli, Rosaria
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2016
Materias:
Themed Section: Research Papers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5429328/
https://ncbi.nlm.nih.gov/pubmed/27684049
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.13637
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares